3D-Micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties

Magnetic Resonance in Medicine

Volumn 45, Issue 3, 2001, Pages 454-460

  Kobayashi, Hisataka ^a   Sato, Noriko ^a   Hiraga, Akira ^a   Saga, Tsuneo ^a   Nakamoto, Yuji ^a   Ueda, Hiroyuki ^a   Konishi, Junji ^a   Togashi, Kaori ^a   Brechbiel, Martin W ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiography; Contrast media; Dendrimer; Magnetic resonance imaging; Microcirculation

Indexed keywords

ANGIOGRAPHY; BLOOD; CONTRAST MEDIA; DENDRIMERS; MACROMOLECULES; MAMMALS; MICROCIRCULATION; MOLECULAR IMAGING; PHARMACOKINETICS; TISSUE;

CANCEROUS TISSUES; CHEMICAL COMPOSITIONS; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; MICRO-VASCULATURE; MR CONTRAST AGENTS; MRI CONTRAST AGENTS; PHARMACOKINETIC PROPERTIES; POLYAMIDOAMINE DENDRIMERS;

MAGNETIC RESONANCE IMAGING;

AMINE; CONTRAST MEDIUM; DENDRIMER; GADOLINIUM; PENTETIC ACID DERIVATIVE; POLYAMIDOAMINE;

ARTICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXCRETION; FEMALE; IMAGE QUALITY; MACROMOLECULE; MAGNETIC RESONANCE ANGIOGRAPHY; MICROVASCULATURE; MOLECULAR SIZE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TISSUE PERFUSION;

EID: 0035105015     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2594(200103)45:3<454::AID-MRM1060>3.0.CO;2-M     Document Type: Article

References (35)

1. Assessing tumor angiogenesis using macromolecular MR imaging contrast media
2. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density
3. Albumin labeled with Gd-DTPA. An intravascular contrast enhancing agent for magnetic resonance blood pool imaging: Preparation and characterization
4. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns
5. A new macromolecule as a contrast agent for MR angiography: Preparation, properties, and animal studies
6. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40
7. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter
8. Metal-chelate-dendrimer-antibody constructs for use in radioimmunotherapy and imaging
9. Functional polymers and dendrimers: Reactivity, molecular architecture, and interfacial energy
10. Starburst dendrimers: Enhanced performance and flexibility for immunoassays
11. Boronated starburst dendrimer-monoclonal antibody immunoconjugates; evaluation as a potential delivery system for neutron capture therapy
12. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody
13. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents
14. Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body
15. Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibody
16. Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rat using neutral dextran
17. Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats
18. Glomerular filtration of proteins: Clearance of anionic, neutral, and cationic horseradish peroxidase in the rat
19. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans
20. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points
21. Gadolinium chloride reduces cytochrome P450: Relevance to chemical-induced hepatotoxicity
22. Gadolinium chloride toxicity in the rat
23. Gadolinium chloride toxicity in the mouse
24. Free gadolinium and gadodiamide, a gadolinium chelate used in magnetic resonance imaging: Evaluation of their in vitro effects on human neutrophil viability
25. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood
26. Immunogenicity in rabbits and mice of an antibody-chelate conjugate: Comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent
27. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: Biodistribution and imaging studies
28. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: An experimental study in rats
29. Are angiostatin and endostatin cures for cancer?
30. Angiogenesis and tumor metastasis
31. The rationale and future potential of angiogenesis inhibitors in neoplasia
32. Science, medicine, and the future. Antivascular therapy: A new approach to cancer treatment
33. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates
34. Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry
35. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor